What is Norac Pharma?
Norac Pharma operates as a premier contract research and manufacturing organization, providing a comprehensive suite of services that span the entire drug development lifecycle. From initial process research and development (R&D) to large-scale API manufacturing, the company serves as a vital partner for pharmaceutical entities requiring precision chemistry and regulatory compliance. Their facility infrastructure is designed to meet rigorous environmental, health, and safety standards, a commitment validated by the SOCMA National Performance Improvement Honor. By maintaining a focus on analytical R&D and preclinical support, Norac Pharma effectively bridges the gap between laboratory-scale innovation and commercial-scale production, positioning itself as an indispensable asset for firms navigating the complexities of modern drug discovery.
How much funding has Norac Pharma raised?
Norac Pharma has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Norac Pharma
PPP
Public-Private Partnership
What's next for Norac Pharma?
With the recent injection of $2M, Norac Pharma is strategically positioned to scale its technical capabilities and expand its footprint in the competitive API market. The company is expected to prioritize the modernization of its manufacturing facilities and the enhancement of its analytical R&D platforms to meet the evolving demands of global pharmaceutical partners. As the industry shifts toward more complex molecular structures and stringent quality requirements, Norac Pharma's focus on process optimization and safety will likely serve as a primary driver for long-term growth. Future initiatives will likely center on deepening client partnerships and increasing throughput, ensuring the firm remains at the forefront of chemical process innovation while maintaining its reputation for operational excellence and regulatory reliability.
See full Norac Pharma company page
